Abstract: The present invention is directed to macrocyclic compounds which inhibit prenyl-protein transferase (FTase) and the prenylation of the oncogene protein Ras. The invention is further directed to chemothera-peutic compositions containing the compounds of this invention and methods for inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras.
Type:
Grant
Filed:
September 7, 2000
Date of Patent:
August 27, 2002
Assignee:
Merck & Co., Inc.
Inventors:
Ian M. Bell, Douglas C. Beshore, Steven N. Gallicchio, C. Blair Zartman